NeuroScientific Biopharmaceuticals Ltd. announced the appointment of Professor Dao-Yi Yu, Head of Physiology and Pharmacology Research, Lions Eye Institute, Perth to the Company's Scientific Advisory Board. Professor Yu leads a world-renowned research team focused on major vision threatening diseases such as glaucoma and retinal vascular disease. His research team was successful in developing several new clinical diagnostics and therapeutics in the ophthalmology field such as a tiny microfistula tube that reduces intraocular pressure that is regulatory approved in the US, Europe and Australia.